Cephalon Inc., which makes neurological drugs, agreed to buy French drug maker Group Lafon for $450 million in cash.
By gaining full control of Lafon's Provigil drug for narcolepsy, Cephalon expects to add about $80 million in sales and 3 cents a share to earnings in 2002. The West Chester, Pa.-based drug maker increased its 2002 earnings forecast to $1.03 a share. Sales will be $400 million to $410 million, Cephalon said.
